The effect of cardiac catheterization upon management of advanced aortic and mitral valve disease.

Abstract:

:We assessed the incremental effect of cardiac catheterization upon the management of 93 adult patients with aortic and/or mitral valve disease, referred for surgical consideration. There were 52 patients with aortic valve disease, 29 with mitral valve disease and 12 with aortic and mitral valve disease. Prior to cardiac catheterization, a detailed unblinded ultrasound assessment of each valve was made utilizing 2D and Doppler ultrasound. Based upon the ultrasound result and the clinical assessment, the patient's cardiologist recorded a grading of valve severity and a management decision for each valve. Following catheterization and coronary angiography, the cardiologist repeated the gradings of valve severity and recorded a final management decision. After catheterization, management changed in nine patients and was unchanged in 84. Reasons for management change included differences between echocardiographic and catheterization assessment of valvular regurgitation (three patients), information on coronary anatomy (two patients), minor differences in assessed aortic valve area (one patient) and left ventricular function (one patient), and confirmation of ultrasound findings where clinical and ultrasound findings had been conflicting before catheterization (two patients). Both mitral and aortic valve disease were present in the three patients in whom management changed as a result of significant differences between echocardiography and catheterization assessment of valvular regurgitation. Management was unchanged in the 16 patients with isolated mitral stenosis. In this study, a combination of clinical and noninvasive assessment including Doppler echocardiography, resulted in a reliable evaluation of valvular disease in a large majority of patients.(ABSTRACT TRUNCATED AT 250 WORDS)

journal_name

Eur Heart J

journal_title

European heart journal

authors

Leitch JW,Mitchell AS,Harris PJ,Fletcher PJ,Bailey BP

subject

Has Abstract

pub_date

1991-05-01 00:00:00

pages

602-7

issue

5

eissn

0195-668X

issn

1522-9645

journal_volume

12

pub_type

杂志文章
  • Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better.

    abstract:AIMS:Our objectives were (i) to compare the discriminatory performance of the Thrombolysis in Myocardial Infarction risk score (TIMI RS), Platelet glycoprotein IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy risk score (PURSUIT RS), and Global Registry of Acute Cardiac Events risk score (GRAC...

    journal_title:European heart journal

    pub_type: 杂志文章,多中心研究

    doi:10.1093/eurheartj/ehm004

    authors: Yan AT,Yan RT,Tan M,Casanova A,Labinaz M,Sridhar K,Fitchett DH,Langer A,Goodman SG

    更新日期:2007-05-01 00:00:00

  • Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice.

    abstract:AIMS:We investigated the influence of type one cannabinoid receptor (CB1) deficiency on acute heart failure (AHF) and the underlying mechanism. Acute heart failure syndrome is an important clinical problem because of its high morbidity and mortality rates. Activation of CB1 induces vascular dilation and reinforces the ...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1093/eurheartj/ehr246

    authors: Liao Y,Bin J,Asakura M,Xuan W,Chen B,Huang Q,Xu D,Ledent C,Takashima S,Kitakaze M

    更新日期:2012-12-01 00:00:00

  • Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire.

    abstract:AIMS:Quantitative analysis of rest-stress myocardial perfusion magnetic resonance imaging (MRI) can provide assessments of regional myocardial perfusion reserve (MPR). The purpose of this study was to compare regional MPR determined by myocardial perfusion MRI with coronary flow reserve (CFR) by intracoronary Doppler f...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1093/eurheartj/ehn521

    authors: Kurita T,Sakuma H,Onishi K,Ishida M,Kitagawa K,Yamanaka T,Tanigawa T,Kitamura T,Takeda K,Ito M

    更新日期:2009-02-01 00:00:00

  • Is hypertriglyceridaemia an independent risk factor for coronary heart disease? The epidemiological evidence.

    abstract::There has been considerable controversy over whether elevated levels of triglycerides, or hypertriglyceridaemia, is an independent risk factor in coronary heart disease (CHD). Discrepancies between findings of univariate and multivariate statistical analyses are likely to be due to the strong inverse correlation betwe...

    journal_title:European heart journal

    pub_type: 杂志文章,评审

    doi:

    authors: Miller M

    更新日期:1998-07-01 00:00:00

  • Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry.

    abstract:AIMS:Hyponatraemia has been shown to be an independent predictor of mortality in selected patients with heart failure enrolled in clinical trials. The predictive value of hyponatraemia has not been evaluated in unselected patients hospitalized with heart failure. METHODS AND RESULTS:OPTIMIZE-HF is a registry and perfo...

    journal_title:European heart journal

    pub_type: 杂志文章,多中心研究

    doi:10.1093/eurheartj/ehl542

    authors: Gheorghiade M,Abraham WT,Albert NM,Gattis Stough W,Greenberg BH,O'Connor CM,She L,Yancy CW,Young J,Fonarow GC,OPTIMIZE-HF Investigators and Coordinators.

    更新日期:2007-04-01 00:00:00

  • Indices of effectiveness of medical and surgical treatment in 40 cases of prosthetic valve endocarditis.

    abstract::Forty patients with prosthetic valve endocarditis (PVE) presenting during a 12-year period at a single hospital were studied. Twenty-six were male and 14 female and ages ranged from 19 to 67 years. During the first six post-operative months, most episodes were caused by staphylococci (38%) and Gram negative bacilli (2...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1093/eurheartj/5.suppl_c.133

    authors: Gayet JL,Etienne J,Malquarti V,Gruer LD,Didier B,Chuzel M,Champsaur G,Chassignolle J,Fleurette J,Delaye J

    更新日期:1984-10-01 00:00:00

  • Comprehensive cardiac rehabilitation: is it cost-effective?

    abstract::A major challenge for all health care systems is to identify the most efficient use of limited and finite resources available for health care. Economic evaluation provides a balance sheet of the benefits, harms and costs for making choices between alternative health care services and is one strategy to assist decision...

    journal_title:European heart journal

    pub_type: 杂志文章,评审

    doi:

    authors: Oldridge NB

    更新日期:1998-11-01 00:00:00

  • Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure.

    abstract:AIMS:We recently found that resting muscle sympathetic nerve activity is inversely related to peak oxygen uptake (VO(2) peak) in patients with heart failure, suggesting a peripheral neurogenic limit to exercise in heart failure. No such relationship was observed in healthy controls. To determine whether this observatio...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1053/euhj.2001.2942

    authors: Notarius CF,Azevedo ER,Parker JD,Floras JS

    更新日期:2002-05-01 00:00:00

  • Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation.

    abstract::Recent innovations have the potential to improve rhythm control therapy in patients with atrial fibrillation (AF). Controlled trials provide new evidence on the effectiveness and safety of rhythm control therapy, particularly in patients with AF and heart failure. This review summarizes evidence supporting the use of ...

    journal_title:European heart journal

    pub_type: 杂志文章,评审

    doi:10.1093/eurheartj/ehz782

    authors: Willems S,Meyer C,de Bono J,Brandes A,Eckardt L,Elvan A,van Gelder I,Goette A,Gulizia M,Haegeli L,Heidbuchel H,Haeusler KG,Kautzner J,Mont L,Ng GA,Szumowski L,Themistoclakis S,Wegscheider K,Kirchhof P

    更新日期:2019-12-07 00:00:00

  • Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

    abstract::Advances in molecular genetics present new opportunities and challenges for cardiologists who manage patients and families with cardiomyopathies. The aims of this position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases are to review the general issues related to ge...

    journal_title:European heart journal

    pub_type: 共识发展会议,杂志文章

    doi:10.1093/eurheartj/ehq271

    authors: Charron P,Arad M,Arbustini E,Basso C,Bilinska Z,Elliott P,Helio T,Keren A,McKenna WJ,Monserrat L,Pankuweit S,Perrot A,Rapezzi C,Ristic A,Seggewiss H,van Langen I,Tavazzi L,European Society of Cardiology Working Group on

    更新日期:2010-11-01 00:00:00

  • Prevalence and significance of asymmetric septal hypertrophy in hypertension: an echocardiographic and clinical study.

    abstract::To assess the prevalence of asymmetric septal hypertrophy (ASH) in hypertensive patients, 613 echocardiographic examinations performed over a period of one year were reviewed. Asymmetric septal hypertrophy (defined by an echocardiographic interventricular septum to left ventricular free wall thickness ratio of greater...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1093/eurheartj/4.suppl_g.1

    authors: Wicker P,Roudaut R,Haissaguere M,Villega-Arino P,Clementy J,Dallocchio M

    更新日期:1983-11-01 00:00:00

  • Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.

    abstract:Aims:Naturally secreted nanovesicles known as exosomes are required for the regenerative effects of cardiosphere-derived cells (CDCs), and exosomes mimic the benefits of CDCs in rodents. Nevertheless, exosomes have not been studied in a translationally realistic large-animal model. We sought to optimize delivery and as...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1093/eurheartj/ehw240

    authors: Gallet R,Dawkins J,Valle J,Simsolo E,de Couto G,Middleton R,Tseliou E,Luthringer D,Kreke M,Smith RR,Marbán L,Ghaleh B,Marbán E

    更新日期:2017-01-14 00:00:00

  • A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial.

    abstract:AIM:We tested the hypothesis that dapagliflozin may regress left ventricular hypertrophy (LVH) in people with type 2 diabetes (T2D). METHODS AND RESULTS:We randomly assigned 66 people (mean age 67 ± 7 years, 38 males) with T2D, LVH, and controlled blood pressure (BP) to receive dapagliflozin 10 mg once daily or placeb...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1093/eurheartj/ehaa419

    authors: Brown AJM,Gandy S,McCrimmon R,Houston JG,Struthers AD,Lang CC

    更新日期:2020-09-21 00:00:00

  • Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial).

    abstract:AIMS:The optimal timing of intervention in non-ST-elevation myocardial infarction (NSTEMI) remains uncertain. The aim of this multicentre trial was to assess whether an immediate invasive approach is superior to an early invasive or a selective invasive approach with respect to reduction of large infarction. METHODS A...

    journal_title:European heart journal

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1093/eurheartj/ehr418

    authors: Thiele H,Rach J,Klein N,Pfeiffer D,Hartmann A,Hambrecht R,Sick P,Eitel I,Desch S,Schuler G,LIPSIA-NSTEMI Trial Group.

    更新日期:2012-08-01 00:00:00

  • A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease.

    abstract:BACKGROUND:Antiarrhythmic drugs are still used for the treatment of ventricular tachyarrhythmias, in combination with implantable cardioverter-defibrillators or without them. AIM OF THE STUDY:In a double-blind randomized crossover design, the short- and long-term efficacy and safety of oral dofetilide or oral sotalol ...

    journal_title:European heart journal

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1053/euhj.2001.2679

    authors: Boriani G,Lubinski A,Capucci A,Niederle R,Kornacewicz-Jack Z,Wnuk-Wojnar AM,Borggrefe M,Brachmann J,Biffi M,Butrous GS,Ventricular Arrhythmias Dofetilide Investigators.

    更新日期:2001-12-01 00:00:00

  • Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome.

    abstract:AIMS:To assess safety, feasibility and short term outcome of pulmonary vein (PV) isolation in paroxysmal atrial fibrillation (AF) with a cryoballoon. METHODS:We consecutively treated 57 patients with a double lumen 23 or 28 mm cryoballoon. The acute results, complications and follow-up over the first three months were...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1093/eurheartj/ehm227

    authors: Van Belle Y,Janse P,Rivero-Ayerza MJ,Thornton AS,Jessurun ER,Theuns D,Jordaens L

    更新日期:2007-09-01 00:00:00

  • High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events.

    abstract:BACKGROUND:While prior work has suggested that a high-grade atrioventricular block (HAVB) in the setting of an acute coronary syndrome (ACS) is associated with in-hospital death, limited information is available on the incidence of, and death associated with, HAVB in ACS patients receiving contemporary management. MET...

    journal_title:European heart journal

    pub_type: 杂志文章,多中心研究

    doi:10.1093/eurheartj/ehu357

    authors: Singh SM,FitzGerald G,Yan AT,Brieger D,Fox KA,López-Sendón J,Yan RT,Eagle KA,Steg PG,Budaj A,Goodman SG

    更新日期:2015-04-21 00:00:00

  • A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years).

    abstract:AIMS:In this study, we compared the clinical outcomes of elderly patients with unprotected left main coronary artery (ULMCA) stenosis treated with either coronary artery bypass grafting (CABG) or drug-eluting stent (DES). METHODS AND RESULTS:From January 2003 to April 2006, 259 patients with ULMCA stenosis and age > o...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1093/eurheartj/ehm403

    authors: Palmerini T,Barlocco F,Santarelli A,Bacchi-Reggiani L,Savini C,Baldini E,Alessi L,Ruffini M,Di Credico G,Piovaccari G,Di Bartolomeo R,Marzocchi A,Branzi A,De Servi S

    更新日期:2007-11-01 00:00:00

  • Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study.

    abstract:AIMS:To determine the sequence of critical cardiovascular events in the progression of heart failure, and whether aetiology or high-dose vs low-dose lisinopril affected these pathways. METHODS AND RESULTS:This was a post-hoc investigation of the ATLAS database, which comprised 3164 patients with chronic heart failure,...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1053/euhj.2000.2570

    authors: Cleland JG,Thygesen K,Uretsky BF,Armstrong P,Horowitz JD,Massie B,Packer M,Poole-Wilson PA,Rydén L,ATLAS investigators.

    更新日期:2001-09-01 00:00:00

  • Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients.

    abstract:AIM:Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) has been suggested as an independent predictor of cardiovascular events in epidemiological studies. We sought to evaluate Lp-PLA(2) as a risk factor for future cardiovascular events in patients with acute coronary syndromes (ACS) and to elucidate the relationshi...

    journal_title:European heart journal

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1093/eurheartj/ehl565

    authors: Oldgren J,James SK,Siegbahn A,Wallentin L

    更新日期:2007-03-01 00:00:00

  • When should we measure lipoprotein (a)?

    abstract::Recently published epidemiological and genetic studies strongly suggest a causal relationship of elevated concentrations of lipoprotein (a) [Lp(a)] with cardiovascular disease (CVD), independent of low-density lipoproteins (LDLs), reduced high density lipoproteins (HDL), and other traditional CVD risk factors. The ath...

    journal_title:European heart journal

    pub_type: 杂志文章,评审

    doi:10.1093/eurheartj/eht053

    authors: Kostner KM,März W,Kostner GM

    更新日期:2013-11-01 00:00:00

  • The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years.

    abstract:AIMS:To investigate the long-term benefits of treatment with angiotensin-converting enzyme (ACE)-inhibitors in patients with myocardial infarction (MI) and left ventricular dysfunction (LVD). METHODS AND RESULTS:In the trandolapril cardiac evaluation (TRACE) study, 1749 patients with LVD (ejection fraction< or =35%) w...

    journal_title:European heart journal

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1093/eurheartj/ehi021

    authors: Buch P,Rasmussen S,Abildstrom SZ,Køber L,Carlsen J,Torp-Pedersen C,TRACE investigators.

    更新日期:2005-01-01 00:00:00

  • Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece.

    abstract::A group of investigators met for two days in Santorini, Greece, to discuss progress in the field of identification and treatment of high risk/vulnerable atherosclerotic plaques and patients. Many differences in the manner in which terms are being utilized were noted. It was recognized that increased understanding of t...

    journal_title:European heart journal

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1016/j.ehj.2004.01.002

    authors: Schaar JA,Muller JE,Falk E,Virmani R,Fuster V,Serruys PW,Colombo A,Stefanadis C,Ward Casscells S,Moreno PR,Maseri A,van der Steen AF

    更新日期:2004-06-01 00:00:00

  • Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study.

    abstract:Aims:To determine tolerability and the optimal dose regimen of the soluble guanylate cyclase stimulator vericiguat in patients with chronic heart failure and preserved ejection fraction (HFpEF). Methods and results:SOCRATES-PRESERVED was a prospective, randomized, placebo-controlled double-blind, Phase 2b dose-finding...

    journal_title:European heart journal

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1093/eurheartj/ehw593

    authors: Pieske B,Maggioni AP,Lam CSP,Pieske-Kraigher E,Filippatos G,Butler J,Ponikowski P,Shah SJ,Solomon SD,Scalise AV,Mueller K,Roessig L,Gheorghiade M

    更新日期:2017-04-14 00:00:00

  • Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina.

    abstract:AIMS:Pre-infarction angina is associated with better outcome after myocardial infarction. The aim of this study was to assess whether pre-infarction angina is associated with decreased no-reflow after coronary recanalization. METHODS AND RESULTS:Twenty-three patients underwent intracoronary myocardial contrast echocar...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1053/euhj.1999.1714

    authors: Karila-Cohen D,Czitrom D,Brochet E,Faraggi M,Seknadji P,Himbert D,Juliard JM,Assayag P,Steg PG

    更新日期:1999-12-01 00:00:00

  • Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.

    abstract:AIMS:Three methods are used to identify dysglycaemia: fasting plasma glucose (FPG), 2-h post-load plasma glucose (2hPG) from the oral glucose tolerance test (OGTT), and glycated haemoglobin A1c (HbA1c). The aim was to describe the yield and concordance of FPG, HbA1c, and 2hPG alone, or in combination, to identify dysgl...

    journal_title:European heart journal

    pub_type: 杂志文章,多中心研究

    doi:10.1093/eurheartj/ehv008

    authors: Gyberg V,De Bacquer D,Kotseva K,De Backer G,Schnell O,Sundvall J,Tuomilehto J,Wood D,Rydén L,EUROASPIRE IV Investigators.

    更新日期:2015-05-14 00:00:00

  • Treatment of calcified aortic stenosis: surgery or percutaneous transluminal aortic valvuloplasty?

    abstract::A total of 546 patients with severe aortic stenosis (AS) were retrospectively reviewed to assess the efficacy of percutaneous transluminal valvuloplasty (PTV) and valve replacement (VR). Of these, 490 underwent VR between 1968 and 1986 (mean age 62 +/- 12 years, 71.7% were in NYHA class III or IV), 68.8% received mech...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1093/eurheartj/9.suppl_e.163

    authors: Acar J,Vahanian A,Slama M,Cormier B,Michel PL,Luxereau P,Farah E,Leborgne O,Dermine P

    更新日期:1988-04-01 00:00:00

  • Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.

    abstract:BACKGROUND:Oral dipyridamole induces accumulation of endogenous adenosine, which in a hypoxic milieu exerts experimentally an angiogenic effect on coronary collateral circulation. A meta-analysis of 13 randomized placebo-controlled trials published between 1960 and 1992 showed evidence of benefit for dipyridamole in th...

    journal_title:European heart journal

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1053/euhj.2001.2623

    authors: Picano E,PISA (Persantin In Stable Angina) study group.

    更新日期:2001-10-01 00:00:00

  • How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts.

    abstract:AIMS:To determine what proportion of patients with heart failure are eligible for cardiac resynchronization therapy (CRT). METHODS AND RESULTS:Eligibility criteria from the trials establishing the efficacy of CRT were applied to two prospective cohorts: the first enrolled patients with newly diagnosed heart failure di...

    journal_title:European heart journal

    pub_type: 杂志文章,多中心研究

    doi:10.1093/eurheartj/ehi446

    authors: McAlister FA,Tu JV,Newman A,Lee DS,Kimber S,Cujec B,Armstrong PW

    更新日期:2006-02-01 00:00:00

  • Risk factors for cardiovascular disease in patients with periodontitis.

    abstract:AIMS:This study compared plasma levels of established risk markers for atherosclerosis and indices of inflammation in 50 patients with severe periodontitis to those in 46 healthy cases. METHODS AND RESULTS:Full blood counts were performed and levels of high density lipoproteins (HDL), total cholesterol, haptoglobin, e...

    journal_title:European heart journal

    pub_type: 杂志文章

    doi:10.1016/j.ehj.2003.09.016

    authors: Buhlin K,Gustafsson A,Pockley AG,Frostegård J,Klinge B

    更新日期:2003-12-01 00:00:00